Emma Holly Palermo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emma Holly Palermo has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Akash R. Wasil
University of Pennsylvania, Philadelphia
5 shared publications - Diego A. Pizzagalli
Noel Drury, M.D. Institute for Translational Depression Discoveries, University of California, Irvine, USA
4 shared publications - Manuel Kuhn
Center for Depression, Anxiety, and Stress Research, McLean Hospital, Belmont, MA, USA
4 shared publications Jacob M. Blank
Center for Depression, Anxiety, and Stress Research, McLean Hospital, Belmont, MA, USA
3 shared publications- Robert J. DeRubeis
Department of Psychology, University of Pennsylvania
3 shared publications - Alexander R. Daros
Department of Psychology, University of Windsor, Windsor, Canada
2 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Context Shapes Need, Receptivity, and Effectiveness: What Emotion Regulation Science Offers Just-in-Time Adaptive Interventions (Preprint)
UNSTRUCTURED Just-in-time adaptive interventions (JITAIs) promise real-time mental health support that are tailored to provide the right support at the right time to each person. Yet most existing JITAIs for mental health are rarely not truly âjust-in-timeâ or âadaptiveâ in practice. Building and refining decision rules based on three components (i.e., need, receptivity, and effectiveness), and incorporating contextual influences on each of these components, can help to propel research on JITAIs forward. We argue that the field of emotion regulation (ER) research has already built an evidence base highlighting the influence of context on three stages of ERâevaluation, implementation, and monitoringâthat map onto the three JITAI components needed to create decision rules. We describe how context maps onto each JITAI component and propose concrete research designs to further evaluate context-dependent need and strategy effectiveness, as well as to experimentally test idiographically predicted strategies in JITAIs. The integration of context into JITAIs can help to refine decision rules and ultimately lead to more personalized, acceptable, and effective interventions.
- 17 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessContext Shapes Need, Receptivity, and Effectiveness: What Emotion Regulation Science Offers Just-in-Time Adaptive Interventions (Preprint)
UNSTRUCTURED Just-in-time adaptive interventions (JITAIs) promise real-time mental health support that are tailored to provide the right support at the right time to each person. Yet most existing JITAIs for mental health are rarely not truly âjust-in-timeâ or âadaptiveâ in practice. Building and refining decision rules based on three components (i.e., need, receptivity, and effectiveness), and incorporating contextual influences on each of these components, can help to propel research on JITAIs forward. We argue that the field of emotion regulation (ER) research has already built an evidence base highlighting the influence of context on three stages of ERâevaluation, implementation, and monitoringâthat map onto the three JITAI components needed to create decision rules. We describe how context maps onto each JITAI component and propose concrete research designs to further evaluate context-dependent need and strategy effectiveness, as well as to experimentally test idiographically predicted strategies in JITAIs. The integration of context into JITAIs can help to refine decision rules and ultimately lead to more personalized, acceptable, and effective interventions.
- Open Access
Acute stress reorganizes pregenual cingulate and subthalamic coupling to approach-avoidance decisions in remitted depression
Major depressive disorder (MDD) is highly recurrent, and psychosocial stress is a central precipitant of relapses. Daily choices require weighing potential rewards against costs, a process disrupted in MDD that may contribute to relapse. Here, we tested whether a psychosocial stressor affects neural and computational mechanisms underlying approach-avoidance decision making in individuals with remitted MDD (rMDD, N=50) and healthy controls (N=74), prioritizing pregenual anterior cingulate cortex (pgACC) and subthalamic nucleus (STN) due to their roles in value integration and decision caution, respectively. Participants performed a dynamic approach-avoidance conflict task with fMRI before and after psychosocial stress. Hierarchical Bayesian drift-diffusion modeling evaluated whether stress modulated computational and neural mechanisms, with trial-wise pgACC and STN activity entered as neural regressors on evidence accumulation and decision threshold, respectively. Before stress, groups did not differ in any decision parameter, but pgACC activity contributed to evidence accumulation toward avoidance in controls only. After stress, rMDD showed larger increases than controls in the impact of both reward and aversiveness on accumulation toward approach and avoidance, respectively, predominantly for net-aversive offers. Furthermore, in rMDD, stress rendered both approach and avoidance decisions more sensitive to pgACC activity, and STN activity was more strongly coupled to the decision threshold than in controls. Finally, stress-induced increases in reward sensitivity in rMDD predicted one-year course of depressive symptoms. Thus, MDD remission is not characterized by a generalized blunting of decision-making, but by a latent circuit difference that acute stress reorganizes and predicts future symptoms.
Open AccessAcute stress reorganizes pregenual cingulate and subthalamic coupling to approach-avoidance decisions in remitted depression
Major depressive disorder (MDD) is highly recurrent, and psychosocial stress is a central precipitant of relapses. Daily choices require weighing potential rewards against costs, a process disrupted in MDD that may contribute to relapse. Here, we tested whether a psychosocial stressor affects neural and computational mechanisms underlying approach-avoidance decision making in individuals with remitted MDD (rMDD, N=50) and healthy controls (N=74), prioritizing pregenual anterior cingulate cortex (pgACC) and subthalamic nucleus (STN) due to their roles in value integration and decision caution, respectively. Participants performed a dynamic approach-avoidance conflict task with fMRI before and after psychosocial stress. Hierarchical Bayesian drift-diffusion modeling evaluated whether stress modulated computational and neural mechanisms, with trial-wise pgACC and STN activity entered as neural regressors on evidence accumulation and decision threshold, respectively. Before stress, groups did not differ in any decision parameter, but pgACC activity contributed to evidence accumulation toward avoidance in controls only. After stress, rMDD showed larger increases than controls in the impact of both reward and aversiveness on accumulation toward approach and avoidance, respectively, predominantly for net-aversive offers. Furthermore, in rMDD, stress rendered both approach and avoidance decisions more sensitive to pgACC activity, and STN activity was more strongly coupled to the decision threshold than in controls. Finally, stress-induced increases in reward sensitivity in rMDD predicted one-year course of depressive symptoms. Thus, MDD remission is not characterized by a generalized blunting of decision-making, but by a latent circuit difference that acute stress reorganizes and predicts future symptoms.
- Open Access
- 1 July 2026
- Published by Center for Open Science in PsyArXiv
Brain age gap, cortisol reactivity, and developmental timing of childhood maltreatment in major depressive disorder
Objective: Major depressive disorder (MDD), childhood maltreatment, and physiological stress responsivity have each been linked to accelerated biological aging, yet how they jointly relate to brain age gap remains unclear. This study investigated whether brain age gap is associated with depression status and severity, the developmental timing and severity of childhood sexual abuse, and cortisol reactivity.Methods: Two independent samples of women (Study 1: N=71; Study 2: N=85) included participants with current MDD, remitted MDD, or healthy controls, with childhood sexual abuse histories. Childhood sexual abuse occurred during ages 5â14 years in Study 1 and 11â18 years in Study 2. Brain age gap was estimated from structural MRI using a machine-learning framework. Associations of brain age gap with maltreatment severity, depression severity, and cortisol responses to acute stress (Study 2) were examined.Results: Brain age gap was associated with childhood maltreatment only among women with current MDD. The direction of association differed according to the developmental timing of childhood sexual abuse, with negative associations following early exposure and positive associations following later exposure. Conversely, brain age gap was related to depression severity only among women without maltreatment histories. Women with current MDD and childhood sexual abuse showed increased cortisol responses to acute stress relative to other groups, and cortisol reactivity exhibited group-dependent nonlinear associations with brain age gap. Conclusions: Brain age gap reflects individual differences related to depression status, childhood maltreatment, and cortisol responsivity. These findings highlight brain age gap as a potential indicator of heterogeneity within depression.
- 1 July 2026
- Published by Center for Open Science in PsyArXiv
Open AccessBrain age gap, cortisol reactivity, and developmental timing of childhood maltreatment in major depressive disorder
Objective: Major depressive disorder (MDD), childhood maltreatment, and physiological stress responsivity have each been linked to accelerated biological aging, yet how they jointly relate to brain age gap remains unclear. This study investigated whether brain age gap is associated with depression status and severity, the developmental timing and severity of childhood sexual abuse, and cortisol reactivity.Methods: Two independent samples of women (Study 1: N=71; Study 2: N=85) included participants with current MDD, remitted MDD, or healthy controls, with childhood sexual abuse histories. Childhood sexual abuse occurred during ages 5â14 years in Study 1 and 11â18 years in Study 2. Brain age gap was estimated from structural MRI using a machine-learning framework. Associations of brain age gap with maltreatment severity, depression severity, and cortisol responses to acute stress (Study 2) were examined.Results: Brain age gap was associated with childhood maltreatment only among women with current MDD. The direction of association differed according to the developmental timing of childhood sexual abuse, with negative associations following early exposure and positive associations following later exposure. Conversely, brain age gap was related to depression severity only among women without maltreatment histories. Women with current MDD and childhood sexual abuse showed increased cortisol responses to acute stress relative to other groups, and cortisol reactivity exhibited group-dependent nonlinear associations with brain age gap. Conclusions: Brain age gap reflects individual differences related to depression status, childhood maltreatment, and cortisol responsivity. These findings highlight brain age gap as a potential indicator of heterogeneity within depression.
- Open Access
- 14 May 2026
- Published by Elsevier in Journal of Mood & Anxiety Disorders
- Vol. 14, 100182
Characterizing emotion dynamics in remitted depression: A network approach using ecological momentary assessment
- 14 May 2026
- Published by Elsevier in Journal of Mood & Anxiety Disorders
- Vol. 14, 100182
Open AccessCharacterizing emotion dynamics in remitted depression: A network approach using ecological momentary assessment
- Open Access
- 23 May 2025
- Published by Center for Open Science in PsyArXiv
Characterizing Emotion Dynamics in Remitted Depression: A Network Approach Using Ecological Momentary Assessment
Background: Abnormalities in emotion dynamics and processes, such as emotional inflexibility and dominance of negative emotions, are characteristic of depression. The extent to which these abnormalities persist following depressive episodes, and represent a vulnerability factor for recurrent depressive episodes, remains unknown. The current study investigated emotion dynamics and their predictive validity in a sample of individuals with remitted depression (rMDD) and healthy controls (HC). Methods: Adults (HC: n=50; rMDD: n=48) completed a three-week ecological momentary assessment protocol, in which they responded to two items probing positive emotions and three items probing negative emotions six times daily. Contemporaneous and temporal networks were constructed using multilevel vector autoregressive models. Density was calculated as a measure of emotional inflexibility and In- and Out-Expected Influence were calculated as measures of centrality. Linear regression models were used to examine if density predicted clinical outcomes at the 6-month follow-up assessment. Results: Individuals with rMDD had significantly denser temporal emotional networks than HC participants. Groups also showed differential patterns of the most influential nodes in temporal and contemporaneous networks. Greater temporal density and contemporaneous density was significantly associated with increased depressive symptoms at the 6-month follow-up, assessed through both clinician-rated and self-report measures. Conclusions: Abnormalities in emotion dynamics persist following remission from depression and can be used to predict future depressive symptoms, suggesting these may represent a vulnerability factor for depression. Future research should study if interventions based on emotion networks targeting maladaptive emotional processes are able to prevent future depression.
- 23 May 2025
- Published by Center for Open Science in PsyArXiv
Open AccessCharacterizing Emotion Dynamics in Remitted Depression: A Network Approach Using Ecological Momentary Assessment
Background: Abnormalities in emotion dynamics and processes, such as emotional inflexibility and dominance of negative emotions, are characteristic of depression. The extent to which these abnormalities persist following depressive episodes, and represent a vulnerability factor for recurrent depressive episodes, remains unknown. The current study investigated emotion dynamics and their predictive validity in a sample of individuals with remitted depression (rMDD) and healthy controls (HC). Methods: Adults (HC: n=50; rMDD: n=48) completed a three-week ecological momentary assessment protocol, in which they responded to two items probing positive emotions and three items probing negative emotions six times daily. Contemporaneous and temporal networks were constructed using multilevel vector autoregressive models. Density was calculated as a measure of emotional inflexibility and In- and Out-Expected Influence were calculated as measures of centrality. Linear regression models were used to examine if density predicted clinical outcomes at the 6-month follow-up assessment. Results: Individuals with rMDD had significantly denser temporal emotional networks than HC participants. Groups also showed differential patterns of the most influential nodes in temporal and contemporaneous networks. Greater temporal density and contemporaneous density was significantly associated with increased depressive symptoms at the 6-month follow-up, assessed through both clinician-rated and self-report measures. Conclusions: Abnormalities in emotion dynamics persist following remission from depression and can be used to predict future depressive symptoms, suggesting these may represent a vulnerability factor for depression. Future research should study if interventions based on emotion networks targeting maladaptive emotional processes are able to prevent future depression.
- 24 February 2025
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 10  (6) , 607-615
Computational Phenotyping of Effort-Based Decision Making in Unmedicated Adults With Remitted Depression
- 24 February 2025
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 10  (6) , 607-615
Computational Phenotyping of Effort-Based Decision Making in Unmedicated Adults With Remitted Depression
- Open Access
- 16 January 2024
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 11  (1) , e50399
Feasibility, Acceptability, and Potential Efficacy of a Self-Guided Internet-Delivered Dialectical Behavior Therapy Intervention for Substance Use Disorders: Randomized Controlled Trial
Background: People with alcohol and substance use disorders (SUDs) often have underlying difficulties in regulating emotions. Although dialectical behavioral therapy is effective for SUDs, it is often difficult to access. Self-guided, internet-delivered dialectical behavioral therapy (iDBT) allows for expanded availability, but few studies have rigorously evaluated it in individuals with SUDs. Objective: This study examines the feasibility, acceptability, and potential efficacy of an iDBT intervention in treatment-seeking adults with SUDs. We hypothesized that iDBT would be feasible, credible, acceptable, and engaging to people with SUDs. We also hypothesized that the immediate versus delayed iDBT group would show comparatively greater improvements and that both groups would show significant improvements over time. Methods: A 12-week, single-blinded, parallel-arm, randomized controlled trial was implemented, with assessments at baseline and at 4 (acute), 8, and 12 weeks (follow-up). A total of 72 community adults aged 18 to 64 years were randomized. The immediate group (n=38) received access to iDBT at baseline, and the delayed group (n=34) received access after 4 weeks. The intervention (Pocket Skills 2.0) was a self-guided iDBT via a website, with immediate access to all content, additional text and email reminders, and additional support meetings as requested. Our primary outcome was substance dependence, with secondary outcomes pertaining to feasibility, clinical outcomes, functional disability, and emotion dysregulation, among other measures. All outcomes were assessed using self-report questionnaires. Results: iDBT was perceived as a credible and acceptable treatment. In terms of feasibility, 94% (68/72) of the participants started iDBT, 13% (9/68) were early dropouts, 35% (24/68) used it for the recommended 8 days in the first month, and 50% (34/68) were still active 4 weeks later. On average, the participants used iDBT for 2 hours and 24 minutes across 10 separate days. In the acute period, no greater benefit was found for the immediate group on substance dependence, although we did find lower depression (b=â2.46; P=.02) and anxiety (b=â2.22; P=.02). At follow-up, there were greater benefits in terms of reduced alcohol (b=â2.00; P=.02) and nonalcoholic substance (b=â3.74; P=.01) consumption in the immediate access group. Both groups demonstrated improvements in substance dependence in the acute (b=â1.73; P<.001) and follow-up period (b=â2.09; P<.001). At follow-up, both groups reported reduced depression, anxiety, suicidal behaviors, emotional dysregulation, and functional disability. Conclusions: iDBT is a feasible and acceptable intervention for patients with SUDs, although methods for improving engagement are warranted. Although results did not support efficacy for the primary outcome at 4 weeks, findings support reductions in substance dependence and other mental health concerns at 12 weeks. Notwithstanding the limitations of this study, the results suggest the potential value of iDBT in the treatment of SUDs and other mental health conditions. Trial Registration: ClinicalTrials.gov NCT05094440; https://clinicaltrials.gov/show/NCT05094440
- 16 January 2024
- Published by JMIR Publications Inc. in JMIR Mental Health
- Vol. 11  (1) , e50399
Open AccessFeasibility, Acceptability, and Potential Efficacy of a Self-Guided Internet-Delivered Dialectical Behavior Therapy Intervention for Substance Use Disorders: Randomized Controlled Trial
Background: People with alcohol and substance use disorders (SUDs) often have underlying difficulties in regulating emotions. Although dialectical behavioral therapy is effective for SUDs, it is often difficult to access. Self-guided, internet-delivered dialectical behavioral therapy (iDBT) allows for expanded availability, but few studies have rigorously evaluated it in individuals with SUDs. Objective: This study examines the feasibility, acceptability, and potential efficacy of an iDBT intervention in treatment-seeking adults with SUDs. We hypothesized that iDBT would be feasible, credible, acceptable, and engaging to people with SUDs. We also hypothesized that the immediate versus delayed iDBT group would show comparatively greater improvements and that both groups would show significant improvements over time. Methods: A 12-week, single-blinded, parallel-arm, randomized controlled trial was implemented, with assessments at baseline and at 4 (acute), 8, and 12 weeks (follow-up). A total of 72 community adults aged 18 to 64 years were randomized. The immediate group (n=38) received access to iDBT at baseline, and the delayed group (n=34) received access after 4 weeks. The intervention (Pocket Skills 2.0) was a self-guided iDBT via a website, with immediate access to all content, additional text and email reminders, and additional support meetings as requested. Our primary outcome was substance dependence, with secondary outcomes pertaining to feasibility, clinical outcomes, functional disability, and emotion dysregulation, among other measures. All outcomes were assessed using self-report questionnaires. Results: iDBT was perceived as a credible and acceptable treatment. In terms of feasibility, 94% (68/72) of the participants started iDBT, 13% (9/68) were early dropouts, 35% (24/68) used it for the recommended 8 days in the first month, and 50% (34/68) were still active 4 weeks later. On average, the participants used iDBT for 2 hours and 24 minutes across 10 separate days. In the acute period, no greater benefit was found for the immediate group on substance dependence, although we did find lower depression (b=â2.46; P=.02) and anxiety (b=â2.22; P=.02). At follow-up, there were greater benefits in terms of reduced alcohol (b=â2.00; P=.02) and nonalcoholic substance (b=â3.74; P=.01) consumption in the immediate access group. Both groups demonstrated improvements in substance dependence in the acute (b=â1.73; P<.001) and follow-up period (b=â2.09; P<.001). At follow-up, both groups reported reduced depression, anxiety, suicidal behaviors, emotional dysregulation, and functional disability. Conclusions: iDBT is a feasible and acceptable intervention for patients with SUDs, although methods for improving engagement are warranted. Although results did not support efficacy for the primary outcome at 4 weeks, findings support reductions in substance dependence and other mental health concerns at 12 weeks. Notwithstanding the limitations of this study, the results suggest the potential value of iDBT in the treatment of SUDs and other mental health conditions. Trial Registration: ClinicalTrials.gov NCT05094440; https://clinicaltrials.gov/show/NCT05094440
- Open Access
- 26 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Feasibility, Acceptability, and Potential Efficacy of a Self-Guided Internet-Delivered Dialectical Behavior Therapy Intervention for Substance Use Disorders: Randomized Controlled Trial (Preprint)
BACKGROUND People with alcohol and substance use disorders (SUDs) often have underlying difficulties in regulating emotions. Although dialectical behavioral therapy is effective for SUDs, it is often difficult to access. Self-guided, internet-delivered dialectical behavioral therapy (iDBT) allows for expanded availability, but few studies have rigorously evaluated it in individuals with SUDs. OBJECTIVE This study examines the feasibility, acceptability, and potential efficacy of an iDBT intervention in treatment-seeking adults with SUDs. We hypothesized that iDBT would be feasible, credible, acceptable, and engaging to people with SUDs. We also hypothesized that the immediate versus delayed iDBT group would show comparatively greater improvements and that both groups would show significant improvements over time. METHODS A 12-week, single-blinded, parallel-arm, randomized controlled trial was implemented, with assessments at baseline and at 4 (acute), 8, and 12 weeks (follow-up). A total of 72 community adults aged 18 to 64 years were randomized. The immediate group (n=38) received access to iDBT at baseline, and the delayed group (n=34) received access after 4 weeks. The intervention (Pocket Skills 2.0) was a self-guided iDBT via a website, with immediate access to all content, additional text and email reminders, and additional support meetings as requested. Our primary outcome was substance dependence, with secondary outcomes pertaining to feasibility, clinical outcomes, functional disability, and emotion dysregulation, among other measures. All outcomes were assessed using self-report questionnaires. RESULTS iDBT was perceived as a credible and acceptable treatment. In terms of feasibility, 94% (68/72) of the participants started iDBT, 13% (9/68) were early dropouts, 35% (24/68) used it for the recommended 8 days in the first month, and 50% (34/68) were still active 4 weeks later. On average, the participants used iDBT for 2 hours and 24 minutes across 10 separate days. In the acute period, no greater benefit was found for the immediate group on substance dependence, although we did find lower depression (b=â2.46; P=.02) and anxiety (b=â2.22; P=.02). At follow-up, there were greater benefits in terms of reduced alcohol (b=â2.00; P=.02) and nonalcoholic substance (b=â3.74; P=.01) consumption in the immediate access group. Both groups demonstrated improvements in substance dependence in the acute (b=â1.73; P<.001) and follow-up period (b=â2.09; P<.001). At follow-up, both groups reported reduced depression, anxiety, suicidal behaviors, emotional dysregulation, and functional disability. CONCLUSIONS iDBT is a feasible and acceptable intervention for patients with SUDs, although methods for improving engagement are warranted. Although results did not support efficacy for the primary outcome at 4 weeks, findings support reductions in substance dependence and other mental health concerns at 12 weeks. Notwithstanding the limitations of this study, the results suggest the potential value of iDBT in the treatment of SUDs and other mental health conditions. CLINICALTRIAL ClinicalTrials.gov NCT05094440; https://clinicaltrials.gov/show/NCT05094440
- 26 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFeasibility, Acceptability, and Potential Efficacy of a Self-Guided Internet-Delivered Dialectical Behavior Therapy Intervention for Substance Use Disorders: Randomized Controlled Trial (Preprint)
BACKGROUND People with alcohol and substance use disorders (SUDs) often have underlying difficulties in regulating emotions. Although dialectical behavioral therapy is effective for SUDs, it is often difficult to access. Self-guided, internet-delivered dialectical behavioral therapy (iDBT) allows for expanded availability, but few studies have rigorously evaluated it in individuals with SUDs. OBJECTIVE This study examines the feasibility, acceptability, and potential efficacy of an iDBT intervention in treatment-seeking adults with SUDs. We hypothesized that iDBT would be feasible, credible, acceptable, and engaging to people with SUDs. We also hypothesized that the immediate versus delayed iDBT group would show comparatively greater improvements and that both groups would show significant improvements over time. METHODS A 12-week, single-blinded, parallel-arm, randomized controlled trial was implemented, with assessments at baseline and at 4 (acute), 8, and 12 weeks (follow-up). A total of 72 community adults aged 18 to 64 years were randomized. The immediate group (n=38) received access to iDBT at baseline, and the delayed group (n=34) received access after 4 weeks. The intervention (Pocket Skills 2.0) was a self-guided iDBT via a website, with immediate access to all content, additional text and email reminders, and additional support meetings as requested. Our primary outcome was substance dependence, with secondary outcomes pertaining to feasibility, clinical outcomes, functional disability, and emotion dysregulation, among other measures. All outcomes were assessed using self-report questionnaires. RESULTS iDBT was perceived as a credible and acceptable treatment. In terms of feasibility, 94% (68/72) of the participants started iDBT, 13% (9/68) were early dropouts, 35% (24/68) used it for the recommended 8 days in the first month, and 50% (34/68) were still active 4 weeks later. On average, the participants used iDBT for 2 hours and 24 minutes across 10 separate days. In the acute period, no greater benefit was found for the immediate group on substance dependence, although we did find lower depression (b=â2.46; P=.02) and anxiety (b=â2.22; P=.02). At follow-up, there were greater benefits in terms of reduced alcohol (b=â2.00; P=.02) and nonalcoholic substance (b=â3.74; P=.01) consumption in the immediate access group. Both groups demonstrated improvements in substance dependence in the acute (b=â1.73; P<.001) and follow-up period (b=â2.09; P<.001). At follow-up, both groups reported reduced depression, anxiety, suicidal behaviors, emotional dysregulation, and functional disability. CONCLUSIONS iDBT is a feasible and acceptable intervention for patients with SUDs, although methods for improving engagement are warranted. Although results did not support efficacy for the primary outcome at 4 weeks, findings support reductions in substance dependence and other mental health concerns at 12 weeks. Notwithstanding the limitations of this study, the results suggest the potential value of iDBT in the treatment of SUDs and other mental health conditions. CLINICALTRIAL ClinicalTrials.gov NCT05094440; https://clinicaltrials.gov/show/NCT05094440
- Open Access
- 26 June 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12, e45852
A Digital Mental Health App Incorporating Wearable Biosensing for Teachers of Children on the Autism Spectrum to Support Emotion Regulation: Protocol for a Pilot Randomized Controlled Trial
Background: As much as 80% of children on the autism spectrum exhibit challenging behaviors (ie, behaviors dangerous to the self or others, behaviors that interfere with learning and development, and behaviors that interfere with socialization) that can have a devastating impact on personal and family well-being, contribute to teacher burnout, and even require hospitalization. Evidence-based practices to reduce these behaviors emphasize identifying triggers (events or antecedents that lead to challenging behaviors); however, parents and teachers often report that challenging behaviors surface with little warning. Exciting recent advances in biometric sensing and mobile computing technology allow the measurement of momentary emotion dysregulation using physiological indexes. Objective: We present the framework and protocol for a pilot trial that will test a mobile digital mental health app, the KeepCalm app. School-based approaches to managing challenging behaviors in children on the autism spectrum are limited by 3 key factors: children on the autism spectrum often have difficulties in communicating their emotions; it is challenging to implement evidence-based, personalized strategies for individual children in group settings; and it is difficult for teachers to track which strategies are successful for each child. KeepCalm aims to address those barriers by communicating childrenâs stress to their teachers using physiological signaling (emotion dysregulation detection), supporting the implementation of emotion regulation strategies via smartphone pop-up notifications of top strategies for each child according to their behavior (emotion regulation strategy implementation), and easing the task of tracking outcomes by providing the childâs educational team with a tool to track the most effective emotion regulation strategies for that child based on physiological stress reduction data (emotion regulation strategy evaluation). Methods: We will test KeepCalm with 20 educational teams of students on the autism spectrum with challenging behaviors (no exclusion based on IQ or speaking ability) in a pilot randomized waitlist-controlled field trial over a 3-month period. We will examine the usability, acceptability, feasibility, and appropriateness of KeepCalm as primary outcomes. Secondary preliminary efficacy outcomes include clinical decision support success, false positives or false negatives of stress alerts, and the reduction of challenging behaviors and emotion dysregulation. We will also examine technical outcomes, including the number of artifacts and the proportion of time children are engaged in high physical movement based on accelerometry data; test the feasibility of our recruitment strategies; and test the response rate and sensitivity to change of our measures, in preparation for a future fully powered large-scale randomized controlled trial. Results: The pilot trial will begin by September 2023. Conclusions: Results will provide key data about important aspects of implementing KeepCalm in preschools and elementary schools and will provide preliminary data about its efficacy to reduce challenging behaviors and support emotion regulation in children on the autism spectrum. Trial Registration: ClinicalTrials.gov NCT05277194; https://www.clinicaltrials.gov/ct2/show/NCT05277194 International Registered Report Identifier (IRRID): PRR1-10.2196/45852
- 26 June 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12, e45852
Open AccessA Digital Mental Health App Incorporating Wearable Biosensing for Teachers of Children on the Autism Spectrum to Support Emotion Regulation: Protocol for a Pilot Randomized Controlled Trial
Background: As much as 80% of children on the autism spectrum exhibit challenging behaviors (ie, behaviors dangerous to the self or others, behaviors that interfere with learning and development, and behaviors that interfere with socialization) that can have a devastating impact on personal and family well-being, contribute to teacher burnout, and even require hospitalization. Evidence-based practices to reduce these behaviors emphasize identifying triggers (events or antecedents that lead to challenging behaviors); however, parents and teachers often report that challenging behaviors surface with little warning. Exciting recent advances in biometric sensing and mobile computing technology allow the measurement of momentary emotion dysregulation using physiological indexes. Objective: We present the framework and protocol for a pilot trial that will test a mobile digital mental health app, the KeepCalm app. School-based approaches to managing challenging behaviors in children on the autism spectrum are limited by 3 key factors: children on the autism spectrum often have difficulties in communicating their emotions; it is challenging to implement evidence-based, personalized strategies for individual children in group settings; and it is difficult for teachers to track which strategies are successful for each child. KeepCalm aims to address those barriers by communicating childrenâs stress to their teachers using physiological signaling (emotion dysregulation detection), supporting the implementation of emotion regulation strategies via smartphone pop-up notifications of top strategies for each child according to their behavior (emotion regulation strategy implementation), and easing the task of tracking outcomes by providing the childâs educational team with a tool to track the most effective emotion regulation strategies for that child based on physiological stress reduction data (emotion regulation strategy evaluation). Methods: We will test KeepCalm with 20 educational teams of students on the autism spectrum with challenging behaviors (no exclusion based on IQ or speaking ability) in a pilot randomized waitlist-controlled field trial over a 3-month period. We will examine the usability, acceptability, feasibility, and appropriateness of KeepCalm as primary outcomes. Secondary preliminary efficacy outcomes include clinical decision support success, false positives or false negatives of stress alerts, and the reduction of challenging behaviors and emotion dysregulation. We will also examine technical outcomes, including the number of artifacts and the proportion of time children are engaged in high physical movement based on accelerometry data; test the feasibility of our recruitment strategies; and test the response rate and sensitivity to change of our measures, in preparation for a future fully powered large-scale randomized controlled trial. Results: The pilot trial will begin by September 2023. Conclusions: Results will provide key data about important aspects of implementing KeepCalm in preschools and elementary schools and will provide preliminary data about its efficacy to reduce challenging behaviors and support emotion regulation in children on the autism spectrum. Trial Registration: ClinicalTrials.gov NCT05277194; https://www.clinicaltrials.gov/ct2/show/NCT05277194 International Registered Report Identifier (IRRID): PRR1-10.2196/45852
- Open Access
- 23 January 2023
- Published by JMIR Publications Inc. in JMIR Preprints
A Digital Mental Health App Incorporating Wearable Biosensing for Teachers of Children on the Autism Spectrum to Support Emotion Regulation: Protocol for a Pilot Randomized Controlled Trial (Preprint)
BACKGROUND As much as 80% of children on the autism spectrum exhibit challenging behaviors (ie, behaviors dangerous to the self or others, behaviors that interfere with learning and development, and behaviors that interfere with socialization) that can have a devastating impact on personal and family well-being, contribute to teacher burnout, and even require hospitalization. Evidence-based practices to reduce these behaviors emphasize identifying triggers (events or antecedents that lead to challenging behaviors); however, parents and teachers often report that challenging behaviors surface with little warning. Exciting recent advances in biometric sensing and mobile computing technology allow the measurement of momentary emotion dysregulation using physiological indexes. OBJECTIVE We present the framework and protocol for a pilot trial that will test a mobile digital mental health app, the KeepCalm app. School-based approaches to managing challenging behaviors in children on the autism spectrum are limited by 3 key factors: children on the autism spectrum often have difficulties in communicating their emotions; it is challenging to implement evidence-based, personalized strategies for individual children in group settings; and it is difficult for teachers to track which strategies are successful for each child. KeepCalm aims to address those barriers by communicating childrenâs stress to their teachers using physiological signaling (emotion dysregulation detection), supporting the implementation of emotion regulation strategies via smartphone pop-up notifications of top strategies for each child according to their behavior (emotion regulation strategy implementation), and easing the task of tracking outcomes by providing the childâs educational team with a tool to track the most effective emotion regulation strategies for that child based on physiological stress reduction data (emotion regulation strategy evaluation). METHODS We will test KeepCalm with 20 educational teams of students on the autism spectrum with challenging behaviors (no exclusion based on IQ or speaking ability) in a pilot randomized waitlist-controlled field trial over a 3-month period. We will examine the usability, acceptability, feasibility, and appropriateness of KeepCalm as primary outcomes. Secondary preliminary efficacy outcomes include clinical decision support success, false positives or false negatives of stress alerts, and the reduction of challenging behaviors and emotion dysregulation. We will also examine technical outcomes, including the number of artifacts and the proportion of time children are engaged in high physical movement based on accelerometry data; test the feasibility of our recruitment strategies; and test the response rate and sensitivity to change of our measures, in preparation for a future fully powered large-scale randomized controlled trial. RESULTS The pilot trial will begin by September 2023. CONCLUSIONS Results will provide key data about important aspects of implementing KeepCalm in preschools and elementary schools and will provide preliminary data about its efficacy to reduce challenging behaviors and support emotion regulation in children on the autism spectrum. CLINICALTRIAL ClinicalTrials.gov NCT05277194; https://www.clinicaltrials.gov/ct2/show/NCT05277194 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/45852
- 23 January 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Digital Mental Health App Incorporating Wearable Biosensing for Teachers of Children on the Autism Spectrum to Support Emotion Regulation: Protocol for a Pilot Randomized Controlled Trial (Preprint)
BACKGROUND As much as 80% of children on the autism spectrum exhibit challenging behaviors (ie, behaviors dangerous to the self or others, behaviors that interfere with learning and development, and behaviors that interfere with socialization) that can have a devastating impact on personal and family well-being, contribute to teacher burnout, and even require hospitalization. Evidence-based practices to reduce these behaviors emphasize identifying triggers (events or antecedents that lead to challenging behaviors); however, parents and teachers often report that challenging behaviors surface with little warning. Exciting recent advances in biometric sensing and mobile computing technology allow the measurement of momentary emotion dysregulation using physiological indexes. OBJECTIVE We present the framework and protocol for a pilot trial that will test a mobile digital mental health app, the KeepCalm app. School-based approaches to managing challenging behaviors in children on the autism spectrum are limited by 3 key factors: children on the autism spectrum often have difficulties in communicating their emotions; it is challenging to implement evidence-based, personalized strategies for individual children in group settings; and it is difficult for teachers to track which strategies are successful for each child. KeepCalm aims to address those barriers by communicating childrenâs stress to their teachers using physiological signaling (emotion dysregulation detection), supporting the implementation of emotion regulation strategies via smartphone pop-up notifications of top strategies for each child according to their behavior (emotion regulation strategy implementation), and easing the task of tracking outcomes by providing the childâs educational team with a tool to track the most effective emotion regulation strategies for that child based on physiological stress reduction data (emotion regulation strategy evaluation). METHODS We will test KeepCalm with 20 educational teams of students on the autism spectrum with challenging behaviors (no exclusion based on IQ or speaking ability) in a pilot randomized waitlist-controlled field trial over a 3-month period. We will examine the usability, acceptability, feasibility, and appropriateness of KeepCalm as primary outcomes. Secondary preliminary efficacy outcomes include clinical decision support success, false positives or false negatives of stress alerts, and the reduction of challenging behaviors and emotion dysregulation. We will also examine technical outcomes, including the number of artifacts and the proportion of time children are engaged in high physical movement based on accelerometry data; test the feasibility of our recruitment strategies; and test the response rate and sensitivity to change of our measures, in preparation for a future fully powered large-scale randomized controlled trial. RESULTS The pilot trial will begin by September 2023. CONCLUSIONS Results will provide key data about important aspects of implementing KeepCalm in preschools and elementary schools and will provide preliminary data about its efficacy to reduce challenging behaviors and support emotion regulation in children on the autism spectrum. CLINICALTRIAL ClinicalTrials.gov NCT05277194; https://www.clinicaltrials.gov/ct2/show/NCT05277194 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/45852